Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations

Overview of attention for article published in International Journal of Nephrology and Renovascular Disease, January 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#22 of 253)
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 1 blog post.

#NephJC Chat Tuesday December 4 at 9 pm EasternWednesday December 5 at 8 pm GMT, 12 noon PacificJAMA. 2018;320(19):2010-2019.